E-LIB Suche - Ergebnisse für: Oyer, Jon A

1

Use of the dTAG system in vivo to degrade CDK2 and CDK5 in ..:

Yenerall, Paul ; Sung, Tae ; Palyada, Kiran...
Toxicological Sciences. 194 (2023) 1 - p. 53-69 , 2023

Link: https://doi.org/10.1093/..

2

PARP1-SNAI2 transcription axis drives resistance to PARP in..:

Ding, Xia ; Zhu, Zhou ; Lapek, John...
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

3

Fluorophosphonate‐Based Degrader Identifies Degradable Seri..:

Field, S. Denise ; Lee, Wankyu ; Dutra, Jason K....
ChemBioChem. 21 (2020) 20 - p. 2916-2920 , 2020

Link: https://doi.org/10.1002/..

4

Emerging Approaches for the Identification of Protein Targe..:

Comess, Kenneth M. ; McLoughlin, Shaun M. ; Oyer, Jon A....
Journal of Medicinal Chemistry. 61 (2018) 19 - p. 8504-8535 , 2018

Link: https://doi.org/10.1021/..

5

An activating mutation of the NSD2 histone methyltransferas..:

Swaroop, Alok ; Oyer, Jon A. ; Will, Christine M....
Oncogene. 38 (2018) 5 - p. 671-686 , 2018

Link: https://doi.org/10.1038/..

6

UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple..:

Ezponda, Teresa ; Dupéré-Richer, Daphné ; Will, Christine M....
Cell Reports. 21 (2017) 3 - p. 628-640 , 2017

Link: https://doi.org/10.1016/..

7

Polycomb- and REST-associated histone deacetylases are inde..:

McGann, James C ; Oyer, Jon A ; Garg, Saurabh...
eLife. 3 (2014) - p. , 2014

Link: https://doi.org/10.7554/..

8

C-terminal domain small phosphatase 1 and MAP kinase recipr..:

Nesti, Edmund ; Corson, Glen M. ; McCleskey, Maxwell..
Proceedings of the National Academy of Sciences. 111 (2014) 37 - p. , 2014

Link: https://doi.org/10.1073/..

9

Aberrantly silenced promoters retain a persistent memory of..:

Oyer, Jon A. ; Yates, Phillip A. ; Godsey, Sarah.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 706 (2011) 1-2 - p. 21-27 , 2011

Link: https://doi.org/10.1016/..

10

Aberrant Epigenetic Silencing Is Triggered by a Transient R..:

Oyer, Jon A. ; Chu, Adrian ; Brar, Sukhmani..
PLoS ONE. 4 (2009) 3 - p. e4832 , 2009

Link: https://doi.org/10.1371/..

11

Use of the dTAG system in vivo to degrade CDK2 and CDK5 in ..:

Yenerall, Paul ; Sung, Tae ; Palyada, Kiran...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306401/. , 2023

Link: http://www.ncbi.nlm.nih...

12

PARP1-SNAI2 transcription axis drives resistance to PARP in..:

Ding, Xia ; Zhu, Zhou ; Lapek, John...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304387/. , 2022

Link: http://www.ncbi.nlm.nih...

13

A Mutation in Histone H2B Represents A New Class Of Oncogen..:

Bennett, Richard L ; Bele, Aditya ; Small, Eliza C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774836/. , 2019

Link: http://www.ncbi.nlm.nih...

14

An Activating Mutation of the NSD2 Histone Methyltransferas..:

Swaroop, Alok ; Oyer, Jon A ; Will, Christine M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358490/. , 2018

Link: http://www.ncbi.nlm.nih...

15

UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple..:

Ezponda, Teresa ; Dupéré-Richer, Daphné ; Will, Christine M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706555/. , 2017

Link: http://www.ncbi.nlm.nih...